Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 299
Selected: 0
NCT IDTitle
NCT01331525The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer
NCT02310997Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)
NCT00967889Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
NCT05848765Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy
NCT02272478Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations
NCT07095517Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
NCT01584258Prostate Advances in Comparative Evidence
NCT01233492Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme
NCT03687645Hyperpolarised 13C-Pyruvate MRI Study
NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
NCT03870152Electrocautery Ablation for the Prevention of Lung Cancer
NCT01390571Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
NCT03728881Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial
NCT03548688Investigation and Detection of Urological Neoplasia in Patients Referred With Suspected Urinary Tract Cancer:
NCT04621370A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer
NCT06289374Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery
NCT01800071A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
NCT05611632Does Screening With the Galleri Test in the NHS Reduce the Likelihood of a Late-stage Cancer Diagnosis in an Asymptomatic Population? A Randomised Clinical Trial
NCT03994783Transplant Antibody-Mediated Rejection: Guiding Effective Treatments
NCT04118192NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer
NCT00907036Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma
NCT05830292Use of DRS Probe and Tracking for In-vivo Application
NCT03212157GlucoCEST MRI in Oncology
NCT01836692Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study
NCT03486730BT1718 in Patients with Advanced Solid Tumours.
NCT05768178DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
NCT01303887A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients
NCT01160926Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial
NCT03177187Combination Study of AZD5069 and Enzalutamide.
NCT01212887Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer
NCT06447064Cancer Loyalty Card Study 2 (CLOCS-2)
NCT04842799Digital Delivery of Information About Genetic Testing for Breast Cancer
NCT03327662Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer
NCT00801736ERCC1 Targeted Trial
NCT07172958Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
NCT00757614Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT01902667Preoperative Imaging in Retroperitoneal Sarcoma
NCT02758587Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)
NCT05635344A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia
NCT05722886DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
NCT03562169The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
NCT01222221Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT03307746A Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell Lymphoma
NCT06320067A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
NCT02688257Assessing Treatment Response in Breast Cancer With Functional Imaging
NCT07002320Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
NCT03024580A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer
NCT05097625Head and Neck Early Relapse Detection Study (HERD)
NCT02071940PLX3397 KIT in Acral aNd mucOsal Melanoma
NCT00006476Suramin in Treating Patients With Recurrent Bladder Cancer